IS1540B - Azithromycin Dihydrate og aðferð við framleiðslu þess - Google Patents

Azithromycin Dihydrate og aðferð við framleiðslu þess

Info

Publication number
IS1540B
IS1540B IS3370A IS3370A IS1540B IS 1540 B IS1540 B IS 1540B IS 3370 A IS3370 A IS 3370A IS 3370 A IS3370 A IS 3370A IS 1540 B IS1540 B IS 1540B
Authority
IS
Iceland
Prior art keywords
production
azithromycin dihydrate
azithromycin
dihydrate
Prior art date
Application number
IS3370A
Other languages
English (en)
Icelandic (is)
Other versions
IS3370A7 (is
Inventor
John Meldrum Allen Douglas
Michael Nepveux Kevin
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22202456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS1540(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS3370A7 publication Critical patent/IS3370A7/is
Publication of IS1540B publication Critical patent/IS1540B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS3370A 1987-07-09 1988-07-07 Azithromycin Dihydrate og aðferð við framleiðslu þess IS1540B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/001612 WO1989000576A1 (en) 1987-07-09 1987-07-09 Azithromycin dihydrate

Publications (2)

Publication Number Publication Date
IS3370A7 IS3370A7 (is) 1989-01-10
IS1540B true IS1540B (is) 1994-01-28

Family

ID=22202456

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3370A IS1540B (is) 1987-07-09 1988-07-07 Azithromycin Dihydrate og aðferð við framleiðslu þess

Country Status (45)

Country Link
US (1) US6268489B1 (enEXAMPLES)
EP (1) EP0298650B1 (enEXAMPLES)
JP (1) JPH0631300B2 (enEXAMPLES)
KR (1) KR900006218B1 (enEXAMPLES)
CN (1) CN1016785B (enEXAMPLES)
AP (1) AP44A (enEXAMPLES)
AR (1) AR243532A1 (enEXAMPLES)
AT (1) ATE72446T1 (enEXAMPLES)
AU (1) AU604553B2 (enEXAMPLES)
BA (1) BA98213B1 (enEXAMPLES)
BG (1) BG47348A3 (enEXAMPLES)
CA (1) CA1314876C (enEXAMPLES)
CS (1) CS272241B2 (enEXAMPLES)
CY (1) CY1776A (enEXAMPLES)
DD (1) DD271705A5 (enEXAMPLES)
DE (1) DE3868296D1 (enEXAMPLES)
DK (1) DK172573B1 (enEXAMPLES)
EG (1) EG18527A (enEXAMPLES)
ES (1) ES2038756T3 (enEXAMPLES)
FI (1) FI91263C (enEXAMPLES)
GR (1) GR3003737T3 (enEXAMPLES)
HK (1) HK127594A (enEXAMPLES)
HU (1) HU211862A9 (enEXAMPLES)
IE (1) IE60354B1 (enEXAMPLES)
IL (1) IL86979A (enEXAMPLES)
IN (1) IN168879B (enEXAMPLES)
IS (1) IS1540B (enEXAMPLES)
LV (1) LV10624B (enEXAMPLES)
MA (1) MA21323A1 (enEXAMPLES)
MX (1) MX12213A (enEXAMPLES)
MY (1) MY103744A (enEXAMPLES)
NO (1) NO171556C (enEXAMPLES)
NZ (1) NZ225338A (enEXAMPLES)
OA (1) OA08743A (enEXAMPLES)
PH (1) PH30953A (enEXAMPLES)
PL (1) PL157145B1 (enEXAMPLES)
PT (1) PT87933B (enEXAMPLES)
RO (1) RO107257B1 (enEXAMPLES)
RU (1) RU2066324C1 (enEXAMPLES)
SG (1) SG27794G (enEXAMPLES)
SI (1) SI8811325A8 (enEXAMPLES)
UA (1) UA27040C2 (enEXAMPLES)
WO (1) WO1989000576A1 (enEXAMPLES)
YU (1) YU45075B (enEXAMPLES)
ZA (1) ZA884925B (enEXAMPLES)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
EP0539223A1 (en) * 1991-10-25 1993-04-28 Ono Pharmaceutical Co., Ltd. Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
CN1034734C (zh) * 1993-12-10 1997-04-30 北京市集才药物研究所 一种新的阿齐红霉素结晶及其制备方法
US5605889A (en) 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
SK282854B6 (sk) 1994-05-06 2002-12-03 Pfizer Inc. Dávkovacia forma s riadeným uvoľňovaním obsahujúca azitromycín
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
AU755315B2 (en) * 1997-10-16 2002-12-12 Pliva-Istrazivacki Institut D.O.O. Novel 3,6-hemiketals from the class of 9a-azalides
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
PT102130A (pt) * 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
HK1043725B (en) 1998-11-30 2005-05-06 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
MXPA01011914A (es) * 1999-05-18 2002-05-06 Pfizer Prod Inc Nuevas formas cristalinas de un antibiotico macrolido.
ATE469910T1 (de) * 1999-06-29 2010-06-15 Sandoz Ag Azithromycinmonohydrat
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
PT1246831E (pt) * 2000-01-04 2008-03-28 Teva Pharma Método de preparação de di-hidrato de azitromicina
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
EP1304326B1 (en) 2000-07-25 2006-03-15 Laboratorio Silanes, S.A. de C.V. Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-ona and obtaining a new form of 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
ES2172417B1 (es) * 2000-07-31 2003-09-16 Sint Quimica Sa Nueva forma mejorada de azitromicina monohidrato de menor higroscopicidad, procedimiento de preparacion y composiciones farmaceuticas que la comprenden.
JP2004506664A (ja) 2000-08-23 2004-03-04 ウォックハート・リミテッド 無水アジトロマイシンの製造法
SK287814B6 (sk) * 2000-11-27 2011-11-04 Sandoz Ag Azithromycin in the form of a monohydrate, a process for its preparation and pharmaceutical compositions comprising same
UA76967C2 (uk) * 2000-11-27 2006-10-16 Сандоз Аг Азитроміцин у формі моногідрату, фармацевтична композиція та спосіб його одержання
IN190080B (enEXAMPLES) * 2001-01-29 2003-06-07 Alembic Ltd
KR100491183B1 (ko) 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
ATE319730T1 (de) * 2001-05-22 2006-03-15 Pfizer Prod Inc Neue kristallforme von azithromycin
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EP1671978A1 (en) 2001-05-22 2006-06-21 Pfizer Products Inc. New Cristal Form of Azithromycin
YU8804A (sh) * 2001-08-21 2006-08-17 Pfizer Products Inc. Jedno-dozni azitromicin
AU2002348884A1 (en) 2001-12-21 2003-07-09 Pfizer Products Inc. Directly compressible formulations of azithromycin
CA2470055A1 (en) * 2001-12-21 2003-07-03 Pfizer Products Inc. Methods for wet granulating azithromycin
MXPA04007427A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Formulaciones de azitromicina granuladas por via seca.
US7376064B2 (en) 2002-02-25 2008-05-20 Samsung Electronics Co., Ltd. Method and apparatus for recording data on optical recording medium
ITMI20021209A1 (it) * 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza
US6855813B2 (en) * 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB2395482A (en) * 2003-07-03 2004-05-26 Jubilant Organosys Ltd Process for preparing non-hygroscopic azithromycin dihydrate
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
ES2600577T3 (es) * 2003-12-04 2017-02-09 Bend Research, Inc. Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
BRPI0416535A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc processo de congelamento por vaporização empregando um extrusor para preparar composições de azitromicina de multiparticulado contendo preferivelmente um poloxámero e um glicerìdeo
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2547239A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
JP2007513139A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 安定性の改善した多粒子組成物
CN1889932A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 制备药用多颗粒的方法
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
RU2260012C1 (ru) * 2004-01-29 2005-09-10 Открытое акционерное общество "Акционерное курганское общество медицинских препаратов и изделий "Синтез" Способ кристаллизации азитромицина дигидрата
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
WO2006011160A1 (en) 2004-06-28 2006-02-02 Alembic Limited Process for the preparation of azithromycin monohydrate isopropanol clathrate
CN1308361C (zh) * 2004-08-09 2007-04-04 大连振邦氟涂料股份有限公司 乙烯－三氟氯乙烯共聚物的制备方法
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
JP2007523896A (ja) * 2004-12-01 2007-08-23 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ アスコマイシンの結晶形態とその調製方法
JP2008524317A (ja) * 2004-12-21 2008-07-10 ファイザー・プロダクツ・インク 腸溶コーティングされたアジスロマイシン多粒子
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CN100366686C (zh) * 2006-01-12 2008-02-06 济南瑞氟化工科技有限公司 一种氟硅超双疏不粘涂料
US20070281894A1 (en) * 2006-06-05 2007-12-06 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted erythromycin analogs
US7704959B2 (en) 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
US20090062220A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched azithromycin
CN101177441B (zh) * 2007-12-05 2012-05-23 浙江耐司康药业有限公司 一种稳定的阿奇霉素一水合物结晶的制备方法
CN101624412B (zh) * 2008-07-10 2012-07-04 刘力 大环内酯类衍生物及其制备和用途
NZ719761A (en) 2008-10-07 2017-11-24 Raptor Pharmaceuticals Inc Aerosol fluoroquinolone formulations for improved pharmacokinetics
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
CN101418026B (zh) * 2008-10-09 2011-05-18 南京工业大学 一种晶型和粒度可控的阿奇霉素结晶工艺
CN101787063B (zh) * 2009-01-23 2012-12-19 刘力 抗感染药物及其制备和用途
AU2010223233A1 (en) 2009-03-13 2011-10-06 Assistance Publique - Hopitaux De Paris Compositions and methods for elimination of Gram-negative bacteria
HRP20191408T1 (hr) 2009-09-04 2019-11-15 Horizon Orphan Llc Uporaba aerosol levofloksacin otopine za liječenje cistične fibroze
CN102911219A (zh) * 2011-08-03 2013-02-06 山东方明药业集团股份有限公司 一种阿齐霉素在水相直接结晶的方法
CN103159811A (zh) * 2011-12-10 2013-06-19 山东方明药业集团股份有限公司 一种阿齐霉素中间体9a-脱氧-9a-氮杂-9a-高红霉素A的制备方法
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN102417531B (zh) * 2011-12-20 2014-06-11 浙江国邦药业有限公司 一种阿奇霉素一水合物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020270A (en) * 1974-05-02 1977-04-26 Societa' Farmaceutici Italia S.P.A. L-lyxohex-1-enopyranose derivative
US4219641A (en) * 1979-06-14 1980-08-26 The Upjohn Company Process for preparing erythromycin succinate
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
YU43402B (en) * 1985-03-04 1989-06-30 Pliva Pharm & Chem Works Process for preparation of 11-aza-10-deoxo-10-dihydroeritromycin "a" by using electro-chemical reduction
WO1989002271A1 (en) 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents

Also Published As

Publication number Publication date
OA08743A (fr) 1989-03-31
YU45075B (en) 1991-08-31
UA27040C2 (uk) 2000-02-28
BA98213B1 (bs) 1999-08-02
CS272241B2 (en) 1991-01-15
NO900077D0 (no) 1990-01-08
EP0298650A2 (en) 1989-01-11
EP0298650B1 (en) 1992-02-05
RO107257B1 (ro) 1993-10-30
EP0298650A3 (en) 1989-11-08
LV10624A (lv) 1995-04-20
WO1989000576A1 (en) 1989-01-26
IS3370A7 (is) 1989-01-10
MX12213A (es) 1993-05-01
ES2038756T3 (es) 1993-08-01
CN1030422A (zh) 1989-01-18
KR890002137A (ko) 1989-04-08
FI91263B (fi) 1994-02-28
US6268489B1 (en) 2001-07-31
PT87933A (pt) 1989-06-30
SG27794G (en) 1994-10-14
EG18527A (en) 1993-10-30
YU132588A (en) 1990-02-28
CY1776A (en) 1995-10-20
NZ225338A (en) 1990-02-26
NO171556B (no) 1992-12-21
PT87933B (pt) 1994-09-30
CS489688A2 (en) 1990-03-14
DK380688D0 (da) 1988-07-08
DD271705A5 (de) 1989-09-13
RU2066324C1 (ru) 1996-09-10
HK127594A (en) 1994-11-25
IL86979A (en) 1992-11-15
AU1883988A (en) 1989-01-12
PH30953A (en) 1997-12-23
AR243532A1 (es) 1993-08-31
DK172573B1 (da) 1999-01-25
IL86979A0 (en) 1988-12-30
DE3868296D1 (de) 1992-03-19
DK380688A (da) 1989-01-10
ZA884925B (en) 1990-02-28
NO900077L (no) 1990-01-08
FI900087A0 (fi) 1990-01-08
AP44A (en) 1989-07-27
CA1314876C (en) 1993-03-23
IE882108L (en) 1989-01-09
CN1016785B (zh) 1992-05-27
IE60354B1 (en) 1994-06-29
FI900087L (fi) 1990-01-08
SI8811325A8 (en) 1996-12-31
PL273590A1 (en) 1989-03-20
MY103744A (en) 1993-09-30
NO171556C (no) 1993-03-31
IN168879B (enEXAMPLES) 1991-06-29
PL157145B1 (en) 1992-04-30
JPH0631300B2 (ja) 1994-04-27
BG47348A3 (bg) 1990-06-15
LV10624B (en) 1995-10-20
KR900006218B1 (ko) 1990-08-25
FI91263C (fi) 1994-06-10
MA21323A1 (fr) 1989-04-01
HU211862A9 (en) 1995-12-28
AP8800093A0 (en) 1988-05-01
AU604553B2 (en) 1990-12-20
ATE72446T1 (de) 1992-02-15
GR3003737T3 (enEXAMPLES) 1993-03-16
JPS6438096A (en) 1989-02-08

Similar Documents

Publication Publication Date Title
IS1540B (is) Azithromycin Dihydrate og aðferð við framleiðslu þess
DK621786D0 (da) Smaerefedt og fremgangsmaade til fremstilling deraf
FI911940L (fi) Sakkaroosi-6-esterin tuotantomenetelmä
NO173781C (no) Selvbaerende keramisk kompositt og fremgangsmaate for fremstilling derav
IS3718A7 (is) Amínóbenzodiazepines og aðferð til framleiðslu þess
IS1304B6 (is) Askorbín 2-fjölfosfat esterar og aðferð við gerð þeirra. (Ascorbate 2-polyphosphate esters and method og making same).
KR880013189A (ko) 초전도성세라믹선상체의제조방법
FI862276L (fi) Saumaton lamelleista koostuva tuote ja menetelmä sen valmistamiseksi
DK290287D0 (da) Antibiotika og fremgangsmaade til fremstilling deraf
IS3022A7 (is) Frosnar eyjar og aðferð við gerð þeirra
PT87630A (pt) Hydraulic cement and process for its production
DK223089A (da) Lysdaemper og fremgangsmaade til fremstilling deraf
PT88440A (pt) Salbutamol-containing plaster and method of producing
KR890700447A (ko) 프릴 생산장치 및 방법
FI885721A0 (fi) Makeutusaine ja menetelmä sen valmistamiseksi
DK450688D0 (da) Konditioneringsmidler og fremstilling deraf
DK269987D0 (da) Enzym og fremgangsmaade til fremstilling deraf
KR890700427A (ko) 세라믹 제품 및 이의 제조방법
DK290485A (da) Cephalosporin-antibiotika og fremgangsmaade til fremstilling heraf
DK614584A (da) Thiazolyleddikesyrederivater og fremgangsmaader til fremstilling deraf
DK585988A (da) Isopolypeptider og fremgangsmaade til fremstilling deraf
DK434984A (da) Antibiotisk forbindelse og fremgangsmaade til fremstilling heraf
DK265288A (da) Oximino-ether-forbindelser og fremgangsmaade til fremstilling deraf
IS3795A7 (is) Cephalosporinafleiður og aðferð til framleiðslu þeirra
DK158885A (da) Cementprodukt og fremgangsmaade til fremstilling deraf